Nifty Future tips

We providing several types of services such as equity tips, free nifty tips, nifty future tips,intraday tips.

Nifty Future tips

We providing several types of services such as equity tips, commodity tips, free nifty tips, nifty future tips, bullion tips, intraday tips, trading tips for you, We Provides proper strategies and planning for investing or trading in stock market.

Nifty Future tips

We providing several types of services such as equity tips, free nifty tips, nifty future tips,intraday tips.

Nifty Future tips

We providing several types of services such as equity tips, free nifty tips, nifty future tips,intraday tips.

Nifty Future tips

We providing several types of services such as equity tips, free nifty tips, nifty future tips,intraday tips.

Nifty Futures Tips Expert

Nifty Futures Tips Expert
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Get Quick Trial Here:

nifty future tips

Friday, 29 April 2016

Wall Street falls as earnings weigh; Dow, S&P up for month


US stocks posted their largest weekly drop in more than two months on Friday as earnings reports continued to weigh, but the S&P 500 and Dow managed to close up for April after strong showings mid-month. 

Company results once more gave the market direction as a 9 percent decline in Gilead Sciences shares weighed the most on both the S&P and the Nasdaq Composite.

The Dow Jones industrial average fell 57.12 points, or 0.32 percent, to 17,773.64, the S&P 500 lost 10.51 points, or 0.51 percent, to 2,065.3 and the Nasdaq Composite dropped 29.93 points, or 0.62 percent, to 4,775.36.

The weekly declines were of 1.3 percent for both the Dow and S&P and the Nasdaq fell 2.7 percent. It was the largest weekly drop for the Dow since the week to Feb. 12, and for the S&P and Nasdaq the declines were the largest going back to Feb. 5.

Read our more services below:
CapitalStars Financial Research Financial Advisory Services 
www.capitalstars.com | T:+91-731-6790000,6669900
screenshot-blog.capitalstars.com 2015-08-04 10-27-20

CS ROCKING PERFORMANCE OF THE DAY-29 APRIL 2016


Nifty Options Tips

STOCK FUTURES:

FUTURES INTRADAY:
JUST DIAL FUTURE  SELL CALL 3 TG 
RELIANCE INFRA FUTURE SELL CALL 2 TG 
MRF FUTURE BUY CALL 1 TG 

NIFTY FUTURES:
BANK NIFTY BUY CALL 3 TG 

OPTION:
HDFC BANK 1120 CALL BUY CALL 3 TG 
RELIANCE INFRA 530 PUT CALL BUY CALL 2 TG 

STOCK CASH

STOCK CASH INTRADAY:
LUPIN BUY  CALL 1 TG 
HUL TECH SELL CALL1 TG (BOOKED AT 756.50)

STOCK CASH  PREMIUM:
DABUR BUY CALL SL TRIGERRED  
LUPIN BUY CALL HOLD FOR TOMORROW


Read our more services below:
CapitalStars Financial Research Financial Advisory Services 
www.capitalstars.com | T:+91-731-6790000,6669900
screenshot-blog.capitalstars.com 2015-08-04 10-27-20


INDIAN EQUITY MARKET WRAP UP-29 APRIL 2016


Stock Market Trading Tips

INDIAN BENCHMARKS: SENSEX CLOSES FLAT ON WEAK GLOBAL CUES, NIFTY 50 SLIPS BELOW 7850

Poor March quarter earnings from ICICI Bank -1.48 % and weak global cues spooked Dalal Street on Friday, causing the equity benchmarks to close flat. 
The S&P Sensex opened cautiously and then traded with gains for about two hours. However, midway through the market lost momentum and slipped into the red. The Nifty50 followed a similar trajectory. 
Weakness in Asian markets didn't help matters while European markets opened in the red, putting fresh pressure on the indices. 
However, the market recovered most of the losses in the last half-an-hour of trade. The 30-share Sensex ended at 25,606.62, up 3.52 points or 0.01 per cent while the Nifty50 closed at 7,849.80, up 0.03 per cent or 2.55 points. 

UPCOMING RESULTS TOMORROW: FEDERAL BANK, L&TFIN, HDFC, ALKALI, TBZ, PARRYSUGAR

HEADLINES OF THE DAY
Lupin surges on re-introducing Methergine Oral Tablets
ICICI Bank Q4FY16 results: Asset quality deteriorates
Ajanta Pharma Q4 consolidated net profit up 43% (YoY)

The crucial resistance for Nifty SPOT is now seen at 7991 and above this 8135. Support for the immediate term is now placed at 7772 and next support will be 7663.

Read our more services below:
CapitalStars Financial Research Financial Advisory Services 
www.capitalstars.com | T:+91-731-6790000,6669900
screenshot-blog.capitalstars.com 2015-08-04 10-27-20


TOP CORPORATE NEWS-29 APRIL 2016


Stock Futures Tips

Shriram Trans Q4: Net Profit at Rs144 Cr
Shriram Trans Q4: Net Profit at Rs144 Cr: Shriram Tran 927.75 -3.79%
NII at Rs1,475 Cr
Total Income at Rs2918 Cr Vs Rs2312.33 Cr (YoY)
FY16 net profit at Rs1178.20 Cr vs Rs1237.81 Cr (YoY)
FY16 total income at Rs10245.26 Cr vs Rs8644.73 Cr (YoY)

ICICI Bank Q4FY16 results: Asset quality deteriorates
ICICI bank has reported deteriorated asset quality for Q4FY16 as G NPA rose by 110 BPS to 5.82% QoQ as accounts worth around Rs7000 crore slipped into NPA, however RBI’s AQR has been completely taken into account.
The Bank reported a modest 6.4% growth in Net interest income while the non interest income was up by 46.1% YoY. Provisions rose sharply by 147.4% YoY owing to Rs3600 crore additional contingent provisioning done during the quarter.
Profit during the quarter came in at Rs702 crore (down 76% YoY) owing to higher provisioning. We currently have a hold rating on the stock and would come out with detailed note post management interaction.

Lupin surges on re-introducing Methergine Oral Tablets
Lupin rose over 2%, touching to Rs1617.65, after the company announced that its US subsidiary has re-introduced Methergine (methylergonovine maleate) Oral Tablets 0.2mg in the US for the prevention and management of postpartum hemorrhage.
Lupin and its US subsidiary, Lupin Pharmaceuticals, Inc. have announced the re-introduction of Methergine (methylergonovine maleate) Oral Tablets 0.2mg in the US for the prevention and management of postpartum hemorrhage (PPH). Methergine is the only FDA-approved oral uterotonic and is a preferred oral agent in the management of PPH, according to guidelines issued by the American Congress of Obstetricians and Gynecologists (ACOG).

Idea Cellular slumps post Q4FY16 earnings
Shares of Idea Cellular slumped 6% to Rs119.35 on NSE post Q4FY16 earnings which beat estimates but share price fell as volume growth remained soft.
Idea cellular posted strong operational performance, its operating profit grew by 15.6% on a sequential basis, backed by pricing growth in voice (+4.7% qoq) as well as data(+2.7% qoq) segment, but the growth volume growth tapered for both the segments at 1.2% and 1.5% qoq).
Higher depreciation & interest cost resulted in 24.7% qoq decline in net earnings.

Ajanta Pharma Q4 consolidated net profit up 43% (YoY)
Ajanta Pharma has announced the following audited Q4 & FY16 results for the quarter & year ended March 31, 2016:
Standalone (YoY)
For the Quarter ended March 31, 2016
The Company has posted a net profit of Rs135.71 crore Vs Rs84.31 crore.
Total Income increased to Rs443.26 crore Vs Rs371.68 crore.

Read our more services below:
CapitalStars Financial Research Financial Advisory Services 
www.capitalstars.com | T:+91-731-6790000,6669900
screenshot-blog.capitalstars.com 2015-08-04 10-27-20

Thursday, 28 April 2016

Sensex, Nifty marginally higher; ICICI falls ahead of Q4 nos


The market gained strength in morning trade with the Sensex rising more than 100 points led by banking & financials, healthcare, IT and FMCG stocks.

The 30-share BSE Sensex rose 124.15 points to 25727.25 and the 50-share NSE Nifty advanced 31.95 points to 7879.20. The broader markets gained 0.4 percent on positive market breadth.

More than two shares advanced for every share declining on Bombay Stock Exchange.

ICICI Bank declined 1 percent ahead of fourth quarter earnings due later today. A CNBC-TV18 poll expects net profit to rise 6.6 percent YoY to Rs 3115.1 crore and net interest income to grow 9.6 percent to Rs 5565.2 crore in Q4.


Read our more services below:
CapitalStars Financial Research Financial Advisory Services 
www.capitalstars.com | T:+91-731-6790000,6669900
screenshot-blog.capitalstars.com 2015-08-04 10-27-20



CS ROCKING PERFORMANCE OF THE DAY-28 APRIL 2016


Nifty Options Tips

STOCK FUTURES:

FUTURES INTRADAY:
JUBLFOOD FUTURE  SELL CALL 3 TG 
DLF FUTURE BUY CALL 2 TG 

OPTION:
YES BANK 920 CALL BUY CALL 3 TG 
BHEL 125 PUT CALL BUY CALL 1 TG 

STOCK CASH

STOCK CASH INTRADAY:
YES BANK BUY  CALL 3 TG 
JUBLFOOD SELL CALL 3 TG 
ABAN BUY CALL 1 TG
DLF BUY CALL 1 TG
ACC BUY CALL 1 TG (MADE HIGH OF 1451)
JUBLFOOD SELL CALL COST EXIT-1261.40-1256.25

STOCK CASH  PREMIUM:
TATAELXSI SELL CALL 3 TG 
YES BANK BUY CALL 1  TG 


Read our more services below:
CapitalStars Financial Research Financial Advisory Services 
www.capitalstars.com | T:+91-731-6790000,6669900
screenshot-blog.capitalstars.com 2015-08-04 10-27-20


INDIAN EQUITY MARKET WRAP UP-28 APRIL 2016


Stock Market Trading Tips

INDIAN BENCHMARKS: SENSEX PLUNGES 451 POINTS AFTER BOJ FED MEET, HDFC-ITC TOP LOSERS

The Bank of Japan's money policy statement this morning was rather benign, but along with that the April series F&O expiry was enough to trigger the biggest intraday plunge in the market since April 5.
Federal Reserve, which had kept key policy rates unchanged at 0.25-0.5 per cent, had raised hope early in the day; the SGX Nifty futures had showed a lot of strength this morning. 
The policy statement of the Bank of Japan, which came in just half-an-hour ahead of the opening bell, played spoiler. What the US Fed could not do, BoJ did.

The 30-share pack eventually closed the day at 25,603.10, down 1.77 per cent or 461.02 points, while the broader Nifty50 ended at 7,847.25, down 132.65 points or 1.66 per cent. 

HDFC (down 3.21 per cent), ITC (down 3 per cent), M&M (down 2.99 per cent), Maruti (down 2.94 per cent), and Gail (down 2.53 per cent) were the biggest losers in the Sensex pack. TCS (up 0.85 per cent), Axis Bank (up 0.59 per cent) and Lupin (up 0.44 per cent) were the only gainers. 

UPCOMING RESULTS TOMORROW: ICICIBANK, IDFC, MARICO, OREROI REALITY, SRTRANSFIN, UPL, INTERGLOBE AVIATION

HEADLINES OF THE DAY
Dabur India Q4 consolidated net profit up 17% (YoY)
DLF launches Mall of India at investment of Rs1700 crores
ACC Q1 consolidated net profit down 4% (YoY)

The crucial resistance for Nifty SPOT is now seen at 7991 and above this 8135. Support for the immediate term is now placed at 7772 and next support will be 7663.

Read our more services below:
CapitalStars Financial Research Financial Advisory Services 
www.capitalstars.com | T:+91-731-6790000,6669900
screenshot-blog.capitalstars.com 2015-08-04 10-27-20


TOP CORPORATE NEWS-28 APRIL 2016


Stock Futures Tips

Dabur India Q4 consolidated net profit up 17% (YoY)
Dabur India has announced the following audited Q4 & FY16 results for the quarter & year ended March 31, 2016:
Standalone
For the Quarter ended March 31, 2016 (YoY)
The Company has posted a net profit of Rs289.03 crore Vs Rs212.94 crore.
Total Income increased to Rs1566.89 crore Vs Rs1429.21 crore.

DLF launches Mall of India at investment of Rs1700 croresa
DLF launches Mall of India (2 million sq ft built at an investment of Rs1700 crore) – Positive for DLF
As per media reports, DLF officially launched Mall of India in Noida. The mall built at an investment of Rs1700 crore is spread across 2 million square feet.
As much as 95% of the space in the mall has been leased out with as many as 14 anchor partners.

ACC Q1 consolidated net profit down 4% (YoY)
ACC Ltd has announced the following results for the quarter ended March 31, 2016
Standalone
For the Quarter ended March 31, 2016 (YoY)
The Company has posted a net profit of Rs232.19 crore Vs Rs240.55 crore.
Total Income has decreased to Rs3039.52 crore Vs Rs3139.22 crore.

Ceat Q4 consolidated net profit up 11% (YoY)
Ceat has announced the following Q4 & FY16 audited results for the quarter & year ended March 31, 2016:
Standalone
For the Quarter ended March 31, 2016 (YoY)
The Company has posted a net profit of Rs102.23 crore Vs Rs89.44 crore.
Total Income decreased to Rs1397.55 crore Vs Rs1431.77 crore.

Aurobindo gets tentative nod from USFDA for Tadalafil
Aurobindo gets tentative nod from USFDA to manufacture and market Tadalafil, used in treating erectile dysfunction and for treatment of pulmonary hypertension – Positive for Aurobindo.

Read our more services below:
CapitalStars Financial Research Financial Advisory Services 
www.capitalstars.com | T:+91-731-6790000,6669900
screenshot-blog.capitalstars.com 2015-08-04 10-27-20


Wednesday, 27 April 2016

INDIAN EQUITY MARKET OUTLOOK-28 APRIL 2016



INDIAN BENCHMARKS Positive opening seen on D-Street as Fed; F&O expiry in focus
The key Indian equity benchmarks are likely to open on a positive note on Thursday tracking a rally across most Asian markets as traders cheered the US Fed’s signal that it will continue to tread on the slow rate hike path, bolstering the lure for risky assets. Dalal Street may see increased volatility today as traders roll over their positions ahead of the April derivative contracts expiry. SGX Nifty is trading 30.50 points lower.ACC, Ambuja Cement, Idea, HCL Tech and Dabur will be in focus as traders eye their quarterly earnings releases today. 

Indian Indices edged higher to post a second session of gains on Wednesday, led by ONGC after crude oil rallied to 2016 highs, but gains were limited ahead of U.S. and Japanese central bank policy decisions. The S&P BSE Sensex and CNX Nifty rose 0.22% respectively.

Global Markets:

Most stock markets in Asia rose Thursday before Japan’s central bank decides whether to ease monetary policy further to boost the sluggish economy.

US stocks closed with mixed results on Wednesday 27 April as the tech sector dipped and the Federal Reserve left interest rates unchanged.

European stocks drifted lower on Wednesday morning as positive corporate news failed to offset nervousness ahead of the Federal Reserve's rate decision later today.

Major Headlines of the day:

Nalco to go for toll-smelting of aluminium in Iran.
Biocon expects more filings this year for biosimilars, drugs.
Tata Motors to issue NCDs to raise Rs300 crore.

Trend in FII flows:   The FIIs were net  sellers of  Rs 411Cr in the cash segment on Wednesday while the DIIs were net buyers of  Rs 295.07 Cr, as per the provisional figures

Read our more services below:
CapitalStars Financial Research Financial Advisory Services 
www.capitalstars.com | T:+91-731-6790000,6669900
screenshot-blog.capitalstars.com 2015-08-04 10-27-20